Welcome to QPS
Custom-Built Research™
Spotlight
QPS is celebrating 25 years in business in the year 2020! This year, we have expanded our capabilities to include RT-qPCR (COVID-19) and serological (novel coronavirus antibodies) testing.
Read MoreQPS has been providing excellence in DMPK services for 25 years. With a focus on Radiolabeled ADME and oligonucleotide studies, QPS provides flexible, response solutions for custom-built DMPK studies.
Read MoreAgility. Flexibility. Speed. QPS showcases an animated logo to demonstrate how we embody the unique spirit of the hummingbird.
QPS publishes weekly blog posts to expound on timely and relevant news. Check out our latest series of COVID-19 blog posts!
Read MoreTOP DOWNLOADED PAPER 2018-2019. Metabolism, Excretion, and Pharmacokinetics of [14C]‐Cefiderocol (S‐649266), a Siderophore Cephalosporin, in Healthy Subjects Following Intravenous Administration.
Read MoreCUSTOMER SATISFACTION IS OUR ABSOLUTE PRIORITY
QPS is working as a contract research organization (CRO) in close collaboration with a large international network of scientists, investigators and professionals. We are operating from strategically located sites throughout Europe, the United States, and Asia Pacific. In every location we focus on selecting the investigators who will be best for your study.
CONNECT WITH US ON YOUR PREFERRED R&D MARKETPLACE:
WHY QPS?
WE'RE AGILE AND FLEXIBLE
QPS is nimble, agile and flexible. QPS has long-standing experience with local authorities and ethics committees, making it possible to find the fastest solution for every study.
WE SPEAK YOUR LANGUAGE
Your timeline is our timeline. All QPS CRAs are fluent in English, and we maintain native speakers for local monitoring to facilitate the communication with investigators.
OUR EXPERIENCE IS VAST
We have extensive experience with virtually all drug targets and treatment types: CNS, GI, Cardiovascular, Dermal and Transdermal, Endocrine, Oncology, Rare Disease, and more. No matter the target, QPS has you covered. Check out our extensive experience across drug targets, treatment types, and therapy areas. We offer both clinical and preclinical CRO services.
OUR QUALITY IS SUPERIOR
We deliver outstanding quality, performance, and services! When you choose to work with QPS, you will gain peace of mind knowing we are meticulously managing every aspect of your clinical trial program. QPS has a wide range of validated models and techniques for comprehensive compound tests from a single source.
A WIDE RANGE OF THERAPEUTIC EXPERTISE
QPS had significant expertise delivering comprehensive contract research organization services across a broad range of Therapeutic Areas. Please click on the “Learn More” button to explore each of these areas in more detail.
How Can We Help You Accelerate Pharmaceutical Breakthroughs?
Let’s TalkCUSTOM-BUILT RESEARCH SERVICE PACKAGES
FULL-SERVICE CONTRACT RESEARCH ORGANIZATION
QPS offers a comprehensive range of clinical research services. Our support for our pharmaceutical, biotechnology, and CRO partners is unrivaled. As a preclinical CRO, we have the experience and knowledge required to take a pharmaceutical product through the testing phase to clinical trials in a timely manner. The breadth and depth of our drug development offerings are foremost in the industry and we look forward to discussing how we can support your needs.
DRUG DISCOVERY
At QPS, we take early drug development seriously. Our expansive Toxicology Laboratory in Taiwan, our renowned DMPK facilities in Delaware, and our world-class Neuropharmacology research center in Austria are the centerpieces of our collaborative efforts. Use our preclinical CRO research to jump-start the drug discovery process.
BIOANALYSIS & GENE THERAPY
As a preclinical CRO with accredited laboratories in Delaware, USA, North Dakota, USA, Austria, the Netherlands, Taiwan, China, and India, QPS is uniquely well positioned to support Global Bioanalysis & Gene Therapy requirements no matter where in the world your study will be conducted.
EARLY PHASE CLINICAL DEVELOPMENT
Early phase clinical development is a core component of QPS’s capabilities, and we have more than 500 Phase I beds across three continents ready for your next early phase clinical trial. Proximity to world-class medical centers and collaboration with world-class Primary Investigators are just two of the things that set QPS apart in this area.
LATE PHASE CLINICAL DEVELOPMENT
Moving beyond Phase I requires an expansive global network of clinical trial sites and highly qualified investigators, coupled with a proven ability to find and recruit patient volunteers across a broad range of indications. QPS offers all these and more!
CLINICAL RESEARCH SERVICES
Behind the scenes, a well-organized, efficient, and effective back office drives data management, statistics, quality assurance, project management, monitoring services, and more. As a full-service clinical research organization, QPS can meet your needs for one service, or provide the full complement of services required to complete your study on time.
NEUROPHAMACOLOGY
QPS has a site in Austria dedicated to all aspects of Neuropharmacology drug discovery and development. Validated transgenic and non-transgenic in vitro and in vivo models cover most targets of AD, PD, HD, and other neurodegenerative diseases. Talk to QPS before you start your next study!
QPS IN THE PUBLIC EYE
We love to meet current and new clients! Check out our news and social media coverage below, and look for a conference where we can meet to get started! If you see content you like, please let us know by “liking” and “sharing”, or shoot us an email to set up a time to chat about your next project. We look forward to hearing from you!
Testimonials
I just want to reiterate how easy and pleasant it has been working with you and QPS. My whole team is very impressed!
We really appreciate your hard work and your willingness to work with us especially for the very early time points! We look forward to working with you for the remainder of the project. Thank you!